{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:22:19Z","timestamp":1786980139307,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015098","name":"Seoul Metropolitan Government Seoul National University Boramae Medical Center","doi-asserted-by":"publisher","award":["03-2020-8"],"award-info":[{"award-number":["03-2020-8"]}],"id":[{"id":"10.13039\/501100015098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We aimed to evaluate the diagnostic accuracy of enzyme-linked immunosorbent assay (ELISA) for anti-muscle specific tyrosine kinase (MuSK) antibody (Ab) in a large cohort of anti-acetylcholine receptor (AChR) Ab-negative generalized myasthenia gravis (MG), and also to investigate clinical contexts for the diagnosis of MuSK MG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study of 160 patients with a clinical suspicion of AChR Ab-negative generalized MG was performed. The serum samples were tested for anti-clustered AChR Ab by cell-based assay (CBA), anti-MuSK Ab by ELISA, CBA and\/or radioimmunoprecipitation assay (RIPA). Clinical data were compared between anti-MuSK Ab-positive MG and double seronegative (AChR and MuSK) MG groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After excluding non-MG and clustered AChR Ab-positive patients, we identified 89 patients as a cohort of AChR Ab-negative generalized MG. Anti-MuSK Ab was positive by ELISA in 22 (24.7%) patients. While CBA identified five additional anti-MuSK Ab-positive patients, the results of ELISA were mostly consistent with CBA and RIPA with Cohen\u2019s kappa of 0.80 and 0.90, respectively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The most frequent differential diagnosis was motor neuron disease particularly of bulbar onset which showed remarkably overlapping clinical and electrophysiological features with MuSK MG at presentation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While confirming the highest sensitivity of CBA for detecting anti-MuSK Ab, our results highlight the clinical pitfalls in making a diagnosis of MuSK MG and may support a diagnostic utility of MuSK-ELISA in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-022-11458-4","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T13:13:01Z","timestamp":1668690781000},"page":"1478-1486","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis"],"prefix":"10.1007","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3588-274X","authenticated-orcid":false,"given":"Young Nam","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Joon","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Kuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Min","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seol-Hee","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Jo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Sung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung Youl","family":"Seok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Seong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohyun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee Hong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunhee","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Seok","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Nam","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk-Won","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyomin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeeyoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong Jin","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanggon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinseok","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Im","family":"Seok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Woong","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Young","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Soo","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Seung","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Jong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Han","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Ho","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"issue":"20","key":"11458_CR1","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1212\/WNL.0b013e3182377fa6","volume":"77","author":"A Evoli","year":"2011","unstructured":"Evoli A, Lindstrom J (2011) Myasthenia gravis with antibodies to MuSK: another step toward solving mystery? Neurology 77(20):1783\u20131784. https:\/\/doi.org\/10.1212\/WNL.0b013e3182377fa6","journal-title":"Neurology"},{"issue":"1","key":"11458_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nyas.13518","volume":"1412","author":"A Evoli","year":"2018","unstructured":"Evoli A, Alboini PE, Damato V et al (2018) Myasthenia gravis with antibodies to MuSK: an update. Ann N Y Acad Sci 1412(1):82\u201389. https:\/\/doi.org\/10.1111\/nyas.13518","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"11458_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3988\/jcn.2016.12.3.340","volume":"12","author":"SY Park","year":"2016","unstructured":"Park SY, Lee JY, Lim NG, Hong YH (2016) Incidence and prevalence of myasthenia gravis in Korea: a population-based study using the national health insurance claims database. J Clin Neurol 12(3):340\u2013344. https:\/\/doi.org\/10.3988\/jcn.2016.12.3.340","journal-title":"J Clin Neurol"},{"issue":"9","key":"11458_CR4","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.autrev.2013.03.001","volume":"12","author":"JJ Verschuuren","year":"2013","unstructured":"Verschuuren JJ, Huijbers MG, Plomp JJ et al (2013) Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4. Autoimmun Rev 12(9):918\u2013923. https:\/\/doi.org\/10.1016\/j.autrev.2013.03.001","journal-title":"Autoimmun Rev"},{"issue":"1","key":"11458_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/mus.22006","volume":"44","author":"JT Guptill","year":"2011","unstructured":"Guptill JT, Sanders DB, Evoli A (2011) Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts. Muscle Nerve 44(1):36\u201340. https:\/\/doi.org\/10.1002\/mus.22006","journal-title":"Muscle Nerve"},{"key":"11458_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10603-9","author":"N K\u00f6nig","year":"2021","unstructured":"K\u00f6nig N, Stetefeld HR, Dohmen C et al (2021) MuSK-antibodies are associated with worse outcome in myasthenic crisis requiring mechanical ventilation. J Neurol. https:\/\/doi.org\/10.1007\/s00415-021-10603-9","journal-title":"J Neurol"},{"issue":"1\u20132","key":"11458_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cccn.2004.05.008","volume":"348","author":"I Matthews","year":"2004","unstructured":"Matthews I, Chen S, Hewer R et al (2004) Muscle-specific receptor tyrosine kinase autoantibodies-a new immunoprecipitation assay. Clin Chim Acta 348(1\u20132):95\u201399. https:\/\/doi.org\/10.1016\/j.cccn.2004.05.008","journal-title":"Clin Chim Acta"},{"issue":"4","key":"11458_CR8","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000357","volume":"4","author":"S Huda","year":"2017","unstructured":"Huda S, Waters P, Woodhall M et al (2017) IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG. Neurol Neuroimmunol Neuroinflamm 4(4):e357. https:\/\/doi.org\/10.1212\/nxi.0000000000000357","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"11458_CR9","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3988\/jcn.2021.17.3.400","volume":"17","author":"MJ Kim","year":"2021","unstructured":"Kim MJ, Kim SW, Kim M et al (2021) Evaluating an in-house cell-based assay for detecting antibodies against muscle-specific tyrosine kinase in myasthenia gravis. J Clin Neurol 17(3):400\u2013408. https:\/\/doi.org\/10.3988\/jcn.2021.17.3.400","journal-title":"J Clin Neurol"},{"issue":"3","key":"11458_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193723","volume":"13","author":"KH Park","year":"2018","unstructured":"Park KH, Waters P, Woodhall M et al (2018) Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features. PLoS\u00a0One 13(3):e0193723. https:\/\/doi.org\/10.1371\/journal.pone.0193723","journal-title":"PLoS\u00a0One"},{"issue":"9","key":"11458_CR11","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/j.clinph.2005.06.003","volume":"116","author":"DE Stickler","year":"2005","unstructured":"Stickler DE, Massey JM, Sanders DB (2005) MuSK-antibody positive myasthenia gravis: clinical and electrodiagnostic patterns. Clin Neurophysiol 116(9):2065\u20132068. https:\/\/doi.org\/10.1016\/j.clinph.2005.06.003","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"11458_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/s0003-4975(00)01595-2","volume":"70","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki A 3rd, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory board of the myasthenia gravis foundation of America. Ann Thorac Surg 70(1):327\u2013334. https:\/\/doi.org\/10.1016\/s0003-4975(00)01595-2","journal-title":"Ann Thorac Surg"},{"issue":"18","key":"11458_CR13","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1212\/WNL.0b013e3181dc1b1e","volume":"74","author":"TM Burns","year":"2010","unstructured":"Burns TM, Conaway M, Sanders DB (2010) The MG Composite: a valid and reliable outcome measure for myasthenia gravis. Neurology 74(18):1434\u20131440. https:\/\/doi.org\/10.1212\/WNL.0b013e3181dc1b1e","journal-title":"Neurology"},{"issue":"7","key":"11458_CR14","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1093\/brain\/awn092","volume":"131","author":"MI Leite","year":"2008","unstructured":"Leite MI, Jacob S, Viegas S et al (2008) IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis. Brain 131(7):1940\u20131952. https:\/\/doi.org\/10.1093\/brain\/awn092","journal-title":"Brain"},{"issue":"6","key":"11458_CR15","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/mus.25154","volume":"54","author":"S Huda","year":"2016","unstructured":"Huda S, Woodhall MR, Vincent A, Heckmann JM (2016) Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort. Muscle Nerve 54(6):1023\u20131029. https:\/\/doi.org\/10.1002\/mus.25154","journal-title":"Muscle Nerve"},{"issue":"1\u20132","key":"11458_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jns.2014.05.037","volume":"343","author":"T Chang","year":"2014","unstructured":"Chang T, Leite MI, Senanayake S et al (2014) Clinical and serological study of myasthenia gravis using both radioimmunoprecipitation and cell-based assays in a South Asian population. J Neurol Sci 343(1\u20132):82\u201387. https:\/\/doi.org\/10.1016\/j.jns.2014.05.037","journal-title":"J Neurol Sci"},{"issue":"9","key":"11458_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/jnnp-2017-315782","volume":"88","author":"A Evoli","year":"2017","unstructured":"Evoli A, Alboini PE, Iorio R, Damato V, Bartoccioni E (2017) Pattern of ocular involvement in myasthenia gravis with MuSK antibodies. J Neurol Neurosurg Psychiatry 88(9):761\u2013763. https:\/\/doi.org\/10.1136\/jnnp-2017-315782","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"11458_CR18","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1001\/archneur.62.6.1002","volume":"62","author":"JB Caress","year":"2005","unstructured":"Caress JB, Hunt CH, Batish SD (2005) Anti-MuSK myasthenia gravis presenting with purely ocular findings. Arch Neurol 62(6):1002\u20131003. https:\/\/doi.org\/10.1001\/archneur.62.6.1002","journal-title":"Arch Neurol"},{"key":"11458_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.605902","volume":"11","author":"A Evoli","year":"2020","unstructured":"Evoli A, Iorio R (2020) Controversies in ocular myasthenia gravis. Front Neurol 11:605902. https:\/\/doi.org\/10.3389\/fneur.2020.605902","journal-title":"Front Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11458-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11458-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11458-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T08:05:16Z","timestamp":1677485116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11458-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["11458"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11458-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,17]]},"assertion":[{"value":"5 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no financial disclosures to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the local ethics committee of Seoul National University, Seoul Metropolitan Government Boramae Medical Center (IRB 16-2014-29). All patients provided written informed consents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}